BLEEDING RISK WITH HEPARIN THERAPY IN CRITICALLY ILL PATIENTS: CAN THROMBOELASTOGRAPHY ASSIST?

被引：0
|
作者：
Volod, Oksana [1 ]
Chaux, George [1 ]
Qin, Xiaotian [1 ]
Kim, Nari [1 ]
Martin-Stone, Sylvia [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2018年 / 93卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E69 / E69
页数：1
相关论文
共 50 条
  • [21] Thromboelastography findings in critically ill COVID-19 patients
    Salem, Nouran
    Atallah, Bassam
    El Nekidy, Wasim S.
    Sadik, Ziad G.
    Park, Woosup Michael
    Mallat, Jihad
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 51 (04) : 961 - 965
  • [22] Gastrointestinal bleeding in critically ill patients: Incidence, risk factors, outcomes
    Baglaenko, Maxim
    Stupin, Victor
    Kahn, Vladimir
    Silouyanov, Sergey
    Bneyan, Violeta
    Levchuk, Nina
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 532 - 532
  • [23] Relationship of thromboelastography and conventional clotting test values with severe bleeding in critically ill patients with coagulopathy: A prospective study
    Casado-Mendez, Manuel
    Fernandez-Pacheco, Jose
    Arellano-Orden, Victoria
    Rodriguez-Martorell, Francisco J.
    Diaz-Martin, Ana
    Pastor de las Heras, Alvaro
    Dusseck-Brutus, Reginald
    Perez-Torres, Ignacio
    Leal-Noval, Santiago R.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 (05) : 671 - 678
  • [24] Monitoring of unfractionated heparin in critically ill patients
    Aarab, R.
    van Es, J.
    de Pont, A. C. J. M.
    Vroom, M. B.
    Middeldorp, S.
    NETHERLANDS JOURNAL OF MEDICINE, 2013, 71 (09): : 466 - 471
  • [25] The use of the activated clotting time for monitoring heparin therapy in critically ill patients
    Jan J. De Waele
    Sebastiaan Van Cauwenberghe
    Eric Hoste
    Dominique Benoit
    Francis Colardyn
    Intensive Care Medicine, 2003, 29 : 325 - 328
  • [26] The use of the activated clotting time for monitoring heparin therapy in critically ill patients
    Jan J. De Waele
    Sebastiaan Van Cauwenberghe
    Eric Hoste
    Dominique Benoit
    Francis Colardyn
    Intensive Care Medicine, 2003, 29 : 664 - 664
  • [27] The use of the activated clotting time for monitoring heparin therapy in critically ill patients
    Waele, JJ
    Cauwenberghe, S
    Hoste, E
    Benoit, D
    Colardyn, F
    INTENSIVE CARE MEDICINE, 2003, 29 (02) : 325 - 328
  • [28] USE OF MULTIPLE MODALITIES OF NEGATIVE PRESSURE WOUND THERAPY CAN ASSIST MANAGEMENT OF COMPLEX WOUNDS IN CRITICALLY ILL PATIENTS
    McElroy, Elizabeth
    Reider, Kersten
    Lemay, Stormy
    JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING, 2019, 46 : S14 - S14
  • [29] Bleeding outcomes in critically ill patients on heparin with discordant aPTT and anti-Xa activity
    Hala Halawi
    Mahmoud M. Sabawi
    Elsie Rizk
    Ahmed A. Mahmoud
    Jenny H. Petkova
    Shiu-Ki Rocky Hui
    Nina Srour
    Kevin R. Donahue
    Journal of Thrombosis and Thrombolysis, 2025, 58 (2) : 210 - 219
  • [30] Correlation between heparin anti-Xa activity and thromboelastography in adult critically ill COVID-19 patients
    Buckley, Mitchell S. S.
    Benanti, Grace E. E.
    Gilbert, Brian
    Meckel, Jordan
    Dzierba, Amy L. L.
    MacLaren, Robert
    PHARMACOTHERAPY, 2023, 43 (08): : 795 - 803
12345